Pituitary, Neuroendocrinology and Puberty P1

hrp0089p1-p194 | Pituitary, Neuroendocrinology and Puberty P1

A 7-Year Update Report of a National, Interdisciplinary Endeavour to Improve Outcomes for Children and Young People Under 19 Years of Age with Hypothalamic Pituitary Axis Tumours (HPAT) Using Multi-site Video Conferencing

hrp0089p1-p195 | Pituitary, Neuroendocrinology and Puberty P1

Long Term Reversibility of Presumed ACTH Deficiency (ACTHd) in Children and Young People (CYP) with Intracranial Germ Cell Tumours (IGCT)

hrp0089p1-p196 | Pituitary, Neuroendocrinology and Puberty P1

Endocrine Follow-up of Children with a History of Brain Tumour: Data from Our Large Cohort at Necker University Hospital, Paris, 2010–2015

hrp0089p1-p197 | Pituitary, Neuroendocrinology and Puberty P1

A Single Centre Experience of Managing a Series of Childhood Macro/Giant-Prolactinoma

hrp0089p1-p198 | Pituitary, Neuroendocrinology and Puberty P1

A National UK Guideline for Managing Pituitary Adenomas in Children and Young People Under 19 Years Developed According to the AGREE II Framework

hrp0089p1-p199 | Pituitary, Neuroendocrinology and Puberty P1

Growth Hormone Deficiency and Cryptorchidism in a Family with Xq26.3 Duplication and Position Effect on SOX3

hrp0089p1-p200 | Pituitary, Neuroendocrinology and Puberty P1

PROKR2 Mutations in Patients with Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiency

hrp0089p1-p201 | Pituitary, Neuroendocrinology and Puberty P1

Anastrozole is Safe as Monotherapy in Early Maturing Girls with Compromised Growth, Further Improving Gain in Predicted Adult Height by the Initial Combination Therapy of an LHRH Analogue and an Aromatase Inhibitor: Results from the ‘Gail’ Study ISRCTN11469487

hrp0089p1-p202 | Pituitary, Neuroendocrinology and Puberty P1

Long-acting Octeotride Treatment in Children with Neurofibromatosis Type 1 - Optic Pathway Tumors and Growth Hormone Excess

hrp0089p1-p203 | Pituitary, Neuroendocrinology and Puberty P1

Serum Concentrations of the Endocrine Disruptors-organochlorine Pesticides (OCPs) in Greek Children with Neurodevelopmental Disorders

hrp0089p1-p204 | Pituitary, Neuroendocrinology and Puberty P1

Whole-exome Sequencing Identifies Novel Pathogenic Variants in Korean Families with Central Precocious Puberty

hrp0089p1-p205 | Pituitary, Neuroendocrinology and Puberty P1

A Paternally Inherited Familial Precocious Puberty Caused by a Novel MKRN3 Frameshift Variant

hrp0089p1-p206 | Pituitary, Neuroendocrinology and Puberty P1

MKRN3 Levels in Girls with Central Precocious Puberty During GnRHa Treatment: A Longitudinal Study

hrp0089p1-p207 | Pituitary, Neuroendocrinology and Puberty P1

Urinary Gonadotropins as a Useful Non-invasive Marker of Central Precocious Puberty

hrp0089p1-p208 | Pituitary, Neuroendocrinology and Puberty P1

Testicular Development and Puberty in Boys with Duchenne Muscular Dystrophy: Results From the ScOT-DMD Study

hrp0089p1-p209 | Pituitary, Neuroendocrinology and Puberty P1

Exposure to BPA and Phthalates and Timing of Puberty in Girls

hrp0089p1-p210 | Pituitary, Neuroendocrinology and Puberty P1

Hypothalamic-pituitary-testicular Axis Response to Sub-maximal Aerobic Exercise, in Pre- and Early- Pubertal Normal Weight and Obese Boys

hrp0089p1-p211 | Pituitary, Neuroendocrinology and Puberty P1

Effect of Pubertal Blockade and Cross-sex Hormone Treatment on the Growth Spurt in Young Transgender Adolescents: A First Report

hrp0089p1-p212 | Pituitary, Neuroendocrinology and Puberty P1

Real-World Safety Data in a Cohort of Children with Noonan Syndrome Treated with GH: Final Results from NordiNet International Outcome Study (IOS) and ANSWER Program

ESPE Abstracts

57th Annual ESPE (ESPE 2018)

Poster Presentations

A 7-Year Update Report of a National, Interdisciplinary Endeavour to Improve Outcomes for Children and Young People Under 19 Years of Age with Hypothalamic Pituitary Axis Tumours (HPAT) Using Multi-site Video Conferencing

Long Term Reversibility of Presumed ACTH Deficiency (ACTHd) in Children and Young People (CYP) with Intracranial Germ Cell Tumours (IGCT)

Endocrine Follow-up of Children with a History of Brain Tumour: Data from Our Large Cohort at Necker University Hospital, Paris, 2010–2015

A Single Centre Experience of Managing a Series of Childhood Macro/Giant-Prolactinoma

A National UK Guideline for Managing Pituitary Adenomas in Children and Young People Under 19 Years Developed According to the AGREE II Framework

Growth Hormone Deficiency and Cryptorchidism in a Family with Xq26.3 Duplication and Position Effect on SOX3

PROKR2 Mutations in Patients with Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiency

Anastrozole is Safe as Monotherapy in Early Maturing Girls with Compromised Growth, Further Improving Gain in Predicted Adult Height by the Initial Combination Therapy of an LHRH Analogue and an Aromatase Inhibitor: Results from the ‘Gail’ Study ISRCTN11469487

Long-acting Octeotride Treatment in Children with Neurofibromatosis Type 1 - Optic Pathway Tumors and Growth Hormone Excess

Serum Concentrations of the Endocrine Disruptors-organochlorine Pesticides (OCPs) in Greek Children with Neurodevelopmental Disorders

Whole-exome Sequencing Identifies Novel Pathogenic Variants in Korean Families with Central Precocious Puberty

A Paternally Inherited Familial Precocious Puberty Caused by a Novel MKRN3 Frameshift Variant

MKRN3 Levels in Girls with Central Precocious Puberty During GnRHa Treatment: A Longitudinal Study

Urinary Gonadotropins as a Useful Non-invasive Marker of Central Precocious Puberty

Testicular Development and Puberty in Boys with Duchenne Muscular Dystrophy: Results From the ScOT-DMD Study

Exposure to BPA and Phthalates and Timing of Puberty in Girls

Hypothalamic-pituitary-testicular Axis Response to Sub-maximal Aerobic Exercise, in Pre- and Early- Pubertal Normal Weight and Obese Boys

Effect of Pubertal Blockade and Cross-sex Hormone Treatment on the Growth Spurt in Young Transgender Adolescents: A First Report

Real-World Safety Data in a Cohort of Children with Noonan Syndrome Treated with GH: Final Results from NordiNet International Outcome Study (IOS) and ANSWER Program

BiosciAbstracts